Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Chronic periprosthetic joint infection (PJI) presents a major challenge in knee arthroplasty, with varying success rates reported for two-stage exchange arthroplasty (EA) and a lack of consensus on managing failures from such procedures. This study evaluated repeat two-stage EA outcomes for knee PJI after initial treatment failure to identify the risk factors for reimplantation unsuitability and reinfection.
Methods: We analyzed 114 patients who underwent repeat EA for chronic knee PJI between 2010 and 2018. From an initial cohort of 1,351 patients, we excluded 231: 18 for incomplete records or protocol non-compliance and 213 for prior revisions. Among the remaining 1,119 patients, 150 experienced reinfection. After excluding 36 who did not undergo repeat EA, the final cohort comprised 114 patients. Outcomes were evaluated using Delphi-based consensus success criteria as follows: healed wounds, no further infection interventions, and no PJI-related mortality.
Results: In our study, 34.2% of the patients did not proceed with reimplantation due to reinfection or ongoing infection, which was influenced by factors such as high Charlson Comorbidity Index scores, recurrence of a microorganism, and shorter intervals between initial arthroplasty and reinfection. Among the reimplanted patients, 44.0% underwent further revision for rereinfection. Kaplan-Meier analysis of 1,119 initial, 75 repeat, and 24 re-repeat two-stage cases revealed 5-year infection-free survival rates of 93, 72, and 43%, respectively. This study identified significant reinfection risks in patients who have repeated infections by the same microorganisms, persistent PJI, or multiple spacer redo procedures. A 39.5% rereinfection rate, including 12 amputations and a 15.8% mortality rate, was observed in this series.
Conclusions: This study underscores the effectiveness of first-time two-stage EA for knee PJI and notes the challenges and lower success rates of subsequent attempts. This emphasizes the importance of identifying high-risk patients for tailored treatment plans and setting realistic expectations of outcomes.
Level Of Evidence: III.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.arth.2025.01.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Significant differences in the rate of periprosthetic joint infections in revision hip and knee arthroplasty depending on the applied definition.
Arch Orthop Trauma Surg
September 2025
Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Background: Differentiating periprosthetic joint infections (PJI) from aseptic failure is challenging in total joint arthroplasty. To date, there is no consensus about the most accurate criteria to diagnose PJI. The current study compares common diagnostic PJI criteria.
View Article and Find Full Text PDFPeriprosthetic joint infection: Time to think outside the box.
Knee Surg Sports Traumatol Arthrosc
September 2025
International Joint Center, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Despite undisputed success of orthopaedic procedures, surgical site infections (SSI) such as periprosthetic joint infection (PJI) continues to compromise the outcome and result in major clinical and economic burden. The overall rate of infection is expected to rise in the future resulting in significant associated mortality and morbidity. Traditional concepts have largely attributed the source of PJI to exogenous pathogens.
View Article and Find Full Text PDFComparison of the Diagnostic Performance of Culture, Histopathology, and mNGS for Periprosthetic Joint Infection Using Periprosthetic Tissue Samples: A Prospective Clinical Study.
Infect Drug Resist
September 2025
School of Basic Medical Sciences, Henan University, Kaifeng, People's Republic of China.
Background: This study evaluated the applicability of histopathology, culture, and Metagenomic next-generation sequencing (mNGS) in diagnosing periprosthetic joint infection (PJI).
Methods: In this prospective trial, 215 consecutive patients with suspected knee PJI were enrolled. Tissue specimens were aseptically collected and processed for histopathological analysis, culture, and mNGS.
Quantification of Vancomycin and Clindamycin in Synovial Tissue and Bone Using Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Ther Drug Monit
September 2025
Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Background: Approximately 1-2% of patients undergoing hip or knee arthroplasty encounter a periprosthetic joint infection (PJI). Currently, the treatment involves revision surgeries and long-term antibiotic therapy. However, too low antibiotic concentrations can lead to treatment failure, whereas excessively high concentrations can lead to adverse events.
View Article and Find Full Text PDFLower synovial leucocyte count and polymorphonuclear percentage reliably differentiate periprosthetic joint infection after unicompartmental knee arthroplasty.
Knee Surg Sports Traumatol Arthrosc
September 2025
Department of Orthopaedic Surgery, Sana Hospital Sommerfeld, Kremmen, Germany.
Purpose: This study aimed to determine diagnostic thresholds for synovial fluid leucocyte count and polymorphonuclear (PMN) percentage to identify the diagnosis periprosthetic joint infection (PJI) in patients with failed unicompartmental knee arthroplasties (UKAs).
Methods: This multicentre retrospective cohort study included 239 patients who underwent revision of an UKA for either septic or aseptic indications at five university-affiliated medical centres. Among these, 30 patients (13%) underwent revision for PJI and 209 (87%) for noninfectious causes.